Wall Street Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AACR
Wall Street Financial Group's ELV Position: Q2 2026 in Review
Wall Street Financial Group sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 160 shares — an estimated $46.8K sold.
Wall Street Financial Group first reported a position in ELV in Q1 2026 and held it in 1 quarter. The position peaked at $46.8K in Q1 2026. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Wall Street Financial Group reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Wall Street Financial Group sold 160 Elevance Health shares in Q2 2026, an estimated $46.8K.
- Wall Street Financial Group first reported a position in Elevance Health in Q1 2026 and held it in 1 quarter.
- Wall Street Financial Group's Elevance Health position peaked at $46.8K in Q1 2026.
- 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.